Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy
{{output}}
In around 30% of patients, non-small cell lung cancer is diagnosed at an advanced but resectable stage. Adding systemic therapy has shown clear benefit over surgery alone in locally advanced disease, and currently, chemo-immunotherapy in the adjuvant or neoadj... ...
